AstraZeneca shares rise as University of Oxford vaccine poised for UK approval
A new study has indicated that 2mln people a week in the UK would need to be vaccinated to avoid a third wave of the coronavirus outbreak
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 26 of 55
Archive
FTSE 100 sees solid post-Christmas gain, but closes off highs as US blue-chips see profit-taking
At the close, the UK blue-chip index was up 100.54 points, or 1.6% at 6,602.65, albeit well below the session peak of 6,676.60
AstraZeneca/Oxford vaccine might be approved within days
“I would expect some news pretty shortly, I doubt we will make Christmas now but just after Christmas I would expect.”
AstraZeneca lung cancer drug receives US regulatory green light
Tagrisso will be used to target the early-stage epidermal growth factor receptor-mutated form of the disease
What's behind AstraZeneca's US$39bn deal for Alexion Pharmaceuticals?
The deal comes six and a half years after the advances of Pfizer were rejected, nixing what would have been the biggest ever takeover of a UK company by a foreign rival
AstraZeneca swoops with US$39bn bid for rare disease specialist Alexion
The acquisition is expected to close in the third quarter of 2021 and produce around US$500mln of savings in three years as well as strengthening cash-flow generation
AstraZeneca to test vaccine combo with Russia's Sputnik as Glaxo's effort falters
Russian scientists have claimed that as the two are both common-cold based treatments combining them would greatly enhance the Astra vaccine,
People with severe allergies told to avoid Pfizer/BioNTech vaccine after two NHS workers have reaction
Chris Whitty says vaccine will greatly reduce hospital admissions
AstraZeneca sells rights to high cholesterol treatment for up to US$350mln
Germany's Grünenthal will be able to sell Crestor in over 30 countries in Europe, except the UK and Spain
AstraZeneca gets upgrade from UBS but 2021 "won't be plain sailing"
After a fall in the shares they are now on a more “palatable” 13% premium to the sector based on 2024 forecast earnings
What are the concerns with the COVID-19 vaccine developed by AstraZeneca and Oxford University?
The results announced earlier this week have sparked criticism across the scientific community
AstraZeneca mulls new coronavirus vaccine trial following results confusion
The pharma giant will look to confirm the 90% efficacy rate the vaccine candidate showed in a questioned portion of initial trials
AstraZeneca faces criticism over COVID-19 vaccine trials results
In the trial that achieved 90% efficacy, there were only 2,300 participants all aged below 55
Will AstraZeneca rebound after slipping on Monday’s COVID-19 vaccine news?
The pharma giant could reap the long-term benefits from higher reputation – ‘no vax’ movements aside – and the economic ties with governments worldwide
Archive
Today's Market View - Anglo Asian Mining: Bezant Resources; Bushveld Resources; Kingston Resources; Vast Resources and more...
Economics US – President Trump hinted at transfer of power to President-elect Biden asking hi administration to cooperate with the transition team . President recommended the General Services Administration that provides transition resource
What are the differences between the COVID-19 vaccines developed by AstraZeneca, Pfizer and Moderna?
The FTSE 100 firm dipped after posting lower efficacy than its competitors, but the upside lies in the bigger picture
AstraZeneca says coronavirus vaccine is 90% effective in one dosing regimen
The jab protected participants from the virus 14 days or more after receiving two doses of the vaccine
AstraZeneca says Imfinzi cancer treatment approved for less frequent dosing option
Patients will be able to go to hospital to receive treatment once per month rather than every two weeks
AstraZeneca COVID-19 vaccine shows encouraging phase II results in peer-reviewed study
Data on the final stage of clinical trials is expected soon
AstraZeneca to release COVID-19 vaccine data imminently, says Jefferies
Analysts said the results should come in “days to weeks” after discussing with the pharma giant’s chief financial officer Marc Dunoyer